{"id":"https://openalex.org/W7225157331","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0114","title":"114 CXCL6 emerges as a novel marker of an immunosuppressive, angiogenic, and epithelial-mesenchymal transition (EMT)-enriched metastatic program in uveal melanoma (UM)","display_name":"114 CXCL6 emerges as a novel marker of an immunosuppressive, angiogenic, and epithelial-mesenchymal transition (EMT)-enriched metastatic program in uveal melanoma (UM)","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225157331","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0114"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0114","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0114","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0114","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A121.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/Suppl_2/A121.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160434101","display_name":"Clara J Oh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Clara J Oh","raw_affiliation_strings":["University of Miami, Miami, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Miami, Miami, FL, USA","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160512211","display_name":"Jingshu Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140103","display_name":"Caris Life Sciences (United States)","ror":"https://ror.org/04wh5hg83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140103"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jingshu Chen","raw_affiliation_strings":["CARIS Life Sciences, Phoenix, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CARIS Life Sciences, Phoenix, AZ, USA","institution_ids":["https://openalex.org/I4210140103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071826146","display_name":"Yasmine Baca","orcid":"https://orcid.org/0000-0003-2130-0611","observed_orcids":["https://orcid.org/0000-0003-2130-0611"]},"institutions":[{"id":"https://openalex.org/I4210140103","display_name":"Caris Life Sciences (United States)","ror":"https://ror.org/04wh5hg83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140103"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yasmine Baca","raw_affiliation_strings":["CARIS Life Sciences, Phoenix, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CARIS Life Sciences, Phoenix, AZ, USA","institution_ids":["https://openalex.org/I4210140103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063694213","display_name":"Nishant S. Gandhi","orcid":"https://orcid.org/0009-0003-0560-5543","observed_orcids":["https://orcid.org/0009-0003-0560-5543"]},"institutions":[{"id":"https://openalex.org/I4210140103","display_name":"Caris Life Sciences (United States)","ror":"https://ror.org/04wh5hg83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140103"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nishant Gandhi","raw_affiliation_strings":["CARIS Life Sciences, Phoenix, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CARIS Life Sciences, Phoenix, AZ, USA","institution_ids":["https://openalex.org/I4210140103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5137116775","display_name":"Andrew Elliott","orcid":"https://orcid.org/0000-0001-8494-8031","observed_orcids":["https://orcid.org/0000-0001-8494-8031"]},"institutions":[{"id":"https://openalex.org/I4210140103","display_name":"Caris Life Sciences (United States)","ror":"https://ror.org/04wh5hg83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140103"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Elliott","raw_affiliation_strings":["CARIS Life Sciences, Phoenix, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CARIS Life Sciences, Phoenix, AZ, USA","institution_ids":["https://openalex.org/I4210140103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052393615","display_name":"Garrett Kraft","orcid":"https://orcid.org/0009-0006-6903-3582","observed_orcids":["https://orcid.org/0009-0006-6903-3582"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Garrett Kraft","raw_affiliation_strings":["University of Miami - School of Medicine, Miami, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Miami - School of Medicine, Miami, FL, USA","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082674870","display_name":"Justin C. Moser","orcid":"https://orcid.org/0000-0002-0643-6759","observed_orcids":["https://orcid.org/0000-0002-0643-6759"]},"institutions":[{"id":"https://openalex.org/I4210130412","display_name":"HonorHealth","ror":"https://ror.org/03szbwj17","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210130412"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin Moser","raw_affiliation_strings":["HonorHealth Research Institute, Scottsdale, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HonorHealth Research Institute, Scottsdale, AZ, USA","institution_ids":["https://openalex.org/I4210130412"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001155783","display_name":"Gino Kim In","orcid":"https://orcid.org/0000-0002-7060-5123","observed_orcids":["https://orcid.org/0000-0002-7060-5123"]},"institutions":[{"id":"https://openalex.org/I4210117038","display_name":"USC Norris Comprehensive Cancer Center","ror":"https://ror.org/01nmyfr60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800154431","https://openalex.org/I4210117038"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gino K In","raw_affiliation_strings":["USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I4210117038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090788292","display_name":"Poorva Vaidya","orcid":"https://orcid.org/0000-0002-5506-4250","observed_orcids":["https://orcid.org/0000-0002-5506-4250"]},"institutions":[{"id":"https://openalex.org/I4390039238","display_name":"UC Irvine Chao Family Comprehensive Cancer Center","ror":"https://ror.org/05gzqy922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I204250578","https://openalex.org/I4390039238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Poorva Vaidya","raw_affiliation_strings":["UC Irvine, Chao Family Comprehensive Cancer Center, Orange, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UC Irvine, Chao Family Comprehensive Cancer Center, Orange, CA, USA","institution_ids":["https://openalex.org/I4390039238"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044615683","display_name":"Jose Lutzky","orcid":"https://orcid.org/0000-0002-9503-2130","observed_orcids":["https://orcid.org/0000-0002-9503-2130"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]},{"id":"https://openalex.org/I4210157065","display_name":"Sylvester Comprehensive Cancer Center","ror":"https://ror.org/0552r4b12","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I145608581","https://openalex.org/I4210101935","https://openalex.org/I4210157065"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jose Lutzky","raw_affiliation_strings":["University of Miami, Sylvester Cancer Center, Miami, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Miami, Sylvester Cancer Center, Miami, FL, USA","institution_ids":["https://openalex.org/I145608581","https://openalex.org/I4210157065"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A121","last_page":"A121"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12989","display_name":"Ocular Disorders and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cxcl6","display_name":"CXCL6","score":0.9150000214576721},{"id":"https://openalex.org/keywords/uveal-melanoma","display_name":"uveal melanoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.8740000128746033},{"id":"https://openalex.org/keywords/bap1-mutation","display_name":"BAP1 mutation","score":0.8849999904632568},{"id":"https://openalex.org/keywords/epithelial-mesenchymal-transition","display_name":"epithelial-mesenchymal transition","score":0.9419999718666077},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.9580000042915344},{"id":"https://openalex.org/keywords/tgf-beta-signaling","display_name":"TGF-beta signaling","score":0.7350000143051147},{"id":"https://openalex.org/keywords/hypoxia","display_name":"hypoxia","score":0.9399999976158142},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.7350000143051147},{"id":"https://openalex.org/keywords/m2-macrophages","display_name":"M2 macrophages","score":0.9819999933242798},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.8640000224113464},{"id":"https://openalex.org/keywords/myeloid-cells","display_name":"myeloid cells","score":0.5809999704360962},{"id":"https://openalex.org/keywords/chemokines","display_name":"chemokines","score":0.7149999737739563},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.7710000276565552},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7260000109672546},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8579999804496765}],"concepts":[{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.7409999966621399},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6394000053405762},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5892999768257141},{"id":"https://openalex.org/C194232998","wikidata":"https://www.wikidata.org/wiki/Q1606712","display_name":"Transition (genetics)","level":3,"score":0.5774000287055969},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.5412999987602234},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.3806999921798706},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31850001215934753},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3021000027656555},{"id":"https://openalex.org/C76419328","wikidata":"https://www.wikidata.org/wiki/Q74419","display_name":"Epithelial\u2013mesenchymal transition","level":4,"score":0.2842000126838684},{"id":"https://openalex.org/C2991914496","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma diagnosis","level":3,"score":0.2248000055551529}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.0114","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0114","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0114","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A121.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:8878e96cc6f742d1b14b2409014fadb1","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/8878e96cc6f742d1b14b2409014fadb1","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 14, Iss Suppl 2 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0114","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0114","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0114","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A121.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225157331.pdf","grobid_xml":"https://content.openalex.org/works/W7225157331.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2321901520","https://openalex.org/W7154701268","https://openalex.org/W4214503874","https://openalex.org/W2161143953","https://openalex.org/W4405931635","https://openalex.org/W2739238612","https://openalex.org/W4220936779","https://openalex.org/W4368375936","https://openalex.org/W1449641140","https://openalex.org/W4400282850"],"abstract_inverted_index":{"Background":[0],"Metastatic":[1],"progression":[2],"is":[3,26],"the":[4,15,42,93,110,145,194,199,289],"major":[5],"driver":[6],"of":[7,47,55,96,178,228,362],"poor":[8],"outcomes":[9],"in":[10,31,50,92,109,127,208,221,278,337,366,372],"uveal":[11],"melanoma":[12],"(UM),":[13],"yet":[14],"molecular":[16],"programs":[17,237],"supporting":[18],"metastatic":[19,51,128,290,338,364],"adaptation":[20],"remain":[21],"incompletely":[22],"understood.":[23],"As":[24],"CXCL6":[25,48,97,203,331,357],"an":[27,333],"inflammatory":[28,334],"chemokine":[29],"implicated":[30],"angiogenesis,":[32,229],"tissue":[33],"remodeling,":[34],"and":[35,44,65,83,120,167,189,198,235,258,271,343,351,368,375],"myeloid":[36,272],"recruitment,":[37],"we":[38],"sought":[39],"to":[40,161,176,282],"define":[41],"biological":[43],"clinical":[45,163],"role":[46],"expression":[49,78,98,204],"UM.Methods":[52],"A":[53],"total":[54],"312":[56],"UM":[57,129,291,339,367],"tumors":[58,87,104,225,280,284],"(43":[59],"eye/local,":[60],"269":[61],"metastatic)":[62],"underwent":[63],"DNA":[64],"RNA":[66],"next":[67],"generation":[68],"sequencing":[69],"at":[70],"Caris":[71],"Life":[72],"Sciences":[73],"(Phoenix,":[74],"AZ).":[75],"Chemokine-related":[76],"differential":[77],"was":[79,142,156,172,205,295],"compared":[80,210,281,300],"between":[81],"BAP1MUT":[82,209],"BAP1WT":[84,212],"UM.":[85],"CXCL6-high":[86,119,224,279,293,316],"were":[88,105,123,134,191],"defined":[89,106],"as":[90,107,358],"those":[91,108],"highest":[94],"quartile":[95,112],"(Q4,":[99],"top":[100],"25%),":[101],"whereas":[102],"CXCL6-low":[103,283,302,322],"lowest":[111],"(Q1,":[113],"bottom":[114],"25%).":[115],"Transcriptomic":[116],"analyses":[117],"comparing":[118],"low":[121],"group":[122,294,303],"performed":[124,143],"using":[125,136,144,193],"ssGSEA":[126,239],"samples.":[130],"Immune":[131,246],"cell":[132],"fractions":[133],"inferred":[135],"quanTIseq":[137],"from":[138,158,174],"RNA-seq.":[139],"Multiple-testing":[140],"correction":[141],"Benjamini-Hochberg":[146],"false":[147],"discovery":[148],"rate":[149],"(FDR)":[150],"method.":[151],"Real-world":[152],"overall":[153],"survival":[154],"(OS)":[155],"assessed":[157,173],"specimen":[159],"collection":[160],"last":[162],"contact":[164],"or":[165],"death,":[166],"time":[168],"on":[169,182],"treatment":[170],"(TOT)":[171],"initiation":[175],"discontinuation":[177],"anti\u2013PD-1":[179],"therapy":[180],"based":[181],"insurance":[183],"claims":[184],"data.":[185],"Hazard":[186],"ratios":[187],"(HR)":[188],"p-values":[190],"calculated":[192],"Cox":[195],"proportional":[196],"hazards":[197],"log-rank":[200],"test,":[201],"respectively.Results":[202],"significantly":[206,249],"increased":[207,250],"with":[211,217,263,297,301],"metastases":[213],"(p":[214,285],"<":[215,244,286,311],"0.01),":[216],"no":[218],"significant":[219],"difference":[220,241],"primary":[222],"site.":[223],"showed":[226,317],"enrichment":[227],"apical":[230],"surface,epithelial-mesenchymal":[231],"transition,":[232],"TGF\u03b2":[233],"signaling,":[234],"hypoxia":[236],"(normalized":[238],"score":[240],"0.06\u20130.18,":[242],"p":[243,310,328],"0.001).":[245],"deconvolution":[247],"demonstrated":[248],"M2":[251,349],"macrophages":[252,266],"(mean":[253],"Z-score":[254],"0.30":[255],"vs.":[256,261,269,276,307,325],"-0.33),":[257],"NK-cells":[259],"(0.47":[260],"-0.52),":[262],"reduced":[264],"M1":[265],"abundance":[267],"(-0.19":[268],"0.17)":[270],"dendritic":[273],"cells":[274],"(-0.22":[275],"0.22)":[277],"0.05).":[287],"In":[288],"cohort,":[292],"associated":[296],"inferior":[298,352],"OS":[299,305],"(median":[304,323],"12.4":[306],"17.2":[308],"month,":[309],"0.005).":[312],"Among":[313],"anti\u2013PD-1-treated":[314],"patients,":[315],"numerically":[318],"shorter":[319],"TOT":[320],"than":[321],"2.3":[324],"4.5":[326],"months,":[327],"=":[329],"0.133).Conclusions":[330],"identifies":[332],"transcriptional":[335],"state":[336],"characterized":[340],"by":[341],"angiogenic":[342],"EMT":[344],"pathway":[345],"activation,":[346],"polarization":[347],"towards":[348],"macrophages,":[350],"survival.":[353],"These":[354],"findings":[355],"support":[356],"a":[359],"candidate":[360],"marker":[361],"aggressive":[363],"remodeling":[365],"warrant":[369],"further":[370],"validation":[371],"independent":[373],"cohorts":[374],"immunotherapy-treated":[376],"populations.":[377]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-11-04T00:00:00"}